Brigit Biofarmaka Teknologi Tbk. vs Siloam International Hospitals Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 500 24h volume), while Siloam International Hospitals Tbk. trades at Rp2,330 (market cap 30.17T, 900 24h volume). The key difference: Siloam International Hospitals Tbk. is far larger — about 183.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Siloam International Hospitals Tbk. is more actively traded (900 versus 500). Which is the better fit depends on your goals.
| OBAT | SILO | |
|---|---|---|
Market Cap | 164.65B | 30.17T |
Volume | 500 | 900 |
Lot | 5 | 9 |
Turnover | 121K | 2.1M |
Average Price | 242 | 2,330 |
Value | 121K | 2.1M |
Indicative Equilibrium Price | 238 | 2,330 |
Indicative Equilibrium Volume | 100 | 8 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Siloam International Hospitals Tbk (the Company) was established under its original name of PT Sentralindo Wirasta on August 3, 1996. The Company started commercial operations in 2010 after the restructuring of the hospital unit of PT Lippo Karawaci Tbk.
Read more on SILO →